Reuters: Health
The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's second treatment for Duchenne muscular dystrophy (DMD).
U.S. FDA gives early approval to Sarepta's newest DMD treatment
U.S. FDA gives early approval to Sarepta's newest DMD treatment
Reuters: Health
The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's second treatment for Duchenne muscular dystrophy (DMD).
Reuters: Health
The U.S. Food and Drug Administration on Thursday granted an early approval to Sarepta Therapeutics Inc's second treatment for Duchenne muscular dystrophy (DMD).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment